Below you'll find a list of all posts that have been categorized as “Medical Marijuana Research”
NORML | November 16, 2017 CHICAGO, IL — The use of oral THC mitigates sleep apnea symptoms compared to placebo, according to clinical trial data published online ahead of print in the journal Sleep. Investigators at the University of Illinois at Chicago assessed the efficacy of dronabinol treatment in 73 adults diagnosed with moderate to severe obstructive sleep apnea (OSA). They reported that oral …
Paul Armentano | November 16, 2017 CHICAGO, IL — More than two out of three medical marijuana patients substitute cannabis in place of opioids, according to survey data compiled by Aclara Research, a Chicago-based consulting firm. Sixty-seven percent of respondents reported that they ceased their opioid use after initiating cannabis therapy. Twenty-nine percent of respondents said that cannabis allowed them to decrease their …
Paul Armentano | November 17, 2017 Chronic pain patients enrolled in a statewide medical cannabis access program are significantly more likely to either reduce or cease their use of opioids as compared to non-enrolled patients suffering from similar pain conditions, according to data published online in the journal PLOS One. A team of investigators at the University of New Mexico assessed opioid prescription …
NORML | November 21, 2017 Heart failure patients with a history of cannabis use possess reduced odds of in-hospital mortality compared to similarly matched controls, according to data published online in the journal Circulation. Investigators assessed data from over six million heart failure patients over a seven-year period. Patients with a history of cannabis use were less likely to suffer from atrial fibrillation …
NORML | November 21, 2017 BOSTON, MA — Substantial clinical trial data exists to support the efficacy of medical cannabis in the treatment of chronic pain conditions, pediatric epilepsy, and multiple sclerosis, according to a literature review published online ahead of print in the journal Polish Archives of Internal Medicine. Investigators from Harvard Medical School and New York Medical College reviewed randomized, placebo-controlled …
NORML | November 11, 2017 INDIANAPOLIS, IN — More than one in five military veterans engage in the use of cannabis for therapeutic purposes, according to nationwide survey data conducted on behalf of The American Legion. The American Legion is the largest veterans’ advocacy organization in the United States. Twenty-two percent of respondents said they “use cannabis to treat a mental or physical condition.” Thirty-nine …
Guest Author | November 3, 2017 ANN ARBOR, MI — A history of cannabis use is not contraindicated in patients undergoing organ transplants, according to data published in the journal Current Psychiatry Reports. Investigators at the University of Michigan assessed the potential role of cannabis consumption in post-transplant complications. They reported, “[R]ecent studies suggest that the overall survival rates in kidney, liver, lung, and …
(Sonya Yruel/Drug Policy Alliance) NORML | October 28, 2017 TEL AVIV, ISRAEL — Patients with Parkinson’s disease report long-term therapeutic benefits from the daily use of medical cannabis, according to data published online ahead of print in the journal Clinical Neuropharmacology. Investigators at Tel Aviv University in Israel conducted a retrospective assessment of the daily use of cannabis in 47 patients with Parkinson’s …
Paul Armentano | October 30, 2017 Members of the US House Committee on Veteran’s Affairs are demanding the Department of Veterans Affairs facilitate protocols to assess the efficacy of medical cannabis in veterans suffering from chronic pain and post-traumatic stress. Minnesota Democrat Tim Walz, along with nine other Democrat members of the Committee, authored an October 26, 2017 letter to …
(Sonya Yruel/Drug Policy Alliance) Paul Armentano | October 20, 2017 Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. Non-alcoholic fatty liver disease is the most prevalent form of liver disease, affecting …
